CN1132603C - Compound Wuduqing capsule of blister beetle - Google Patents

Compound Wuduqing capsule of blister beetle Download PDF

Info

Publication number
CN1132603C
CN1132603C CN00122180A CN00122180A CN1132603C CN 1132603 C CN1132603 C CN 1132603C CN 00122180 A CN00122180 A CN 00122180A CN 00122180 A CN00122180 A CN 00122180A CN 1132603 C CN1132603 C CN 1132603C
Authority
CN
China
Prior art keywords
accounts
radix
herba
mylabris
materials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN00122180A
Other languages
Chinese (zh)
Other versions
CN1337250A (en
Inventor
尹秀平
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN00122180A priority Critical patent/CN1132603C/en
Publication of CN1337250A publication Critical patent/CN1337250A/en
Application granted granted Critical
Publication of CN1132603C publication Critical patent/CN1132603C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The present invention relates to compound Wuduqing capsules of blister beetle. The present invention is characterized in that blister beetle and other materials are used as principal raw materials, and supplementary materials comprise liquoric root, mongolian snakegourd root, danshen root, tangerine peel, mongolian dandelion herb, spreading hedyotis herb, etc. The making method comprises the following steps: respectively selecting and drying all the raw materials of traditional Chinese medicine; processing the materials into powder to sieve; separately storing the materials; preparing the materials according to the proportion of formulation to evenly mix; loading 0.15 to 0.6 gram of medicinal powder in each capsule. The present invention has simple technology, keeps the original ingredients of all traditional Chinese medicine, is convenient to take, and overcomes the defects that because the decoction of traditional Chinese medicine needs cooking, and the effective ingredients of the medicine can not be fully utilized.

Description

FUFANG BANMAO JIAONANG
The present invention relates to the Chinese medicine capsule of a kind of treatment five poisonous creatures: scorpion, viper, centipede, house lizard, toad (furuncle, skin ulcer, carbuncle, cellulitis, erysipelas), especially a kind of compositions is primary raw material is controlled the sick medicine of the five poisonous creatures: scorpion, viper, centipede, house lizard, toad (furuncle, skin ulcer, carbuncle, cellulitis, erysipelas) as preparation a FUFANG BANMAO JIAONANG with Mylabris, dry maxima skin etc.
The five poisonous creatures: scorpion, viper, centipede, house lizard, toad that the traditional Chinese medical science was referred to as i.e. " furuncle, skin ulcer, carbuncle, cellulitis, erysipelas ", at present on tcm clinical practice, as: the treatment thromboangiitis obliterans, this disease belongs to traditional Chinese medical science necrosis model and raises, " pyretic toxicity the is stopped up knot " syndrome that is showed, general adopt " SIMIAOYONGAN TANG ", its pharmacological action is " heat-clearing and toxic substances removing, an inrigorating qi and promoting blood circulation "; Or " yang deficiency cold coagulation " syndrome that adopts " Gu Butang " diagnosis and treatment thromboangiitis obliterans to be showed, its pharmacological action is " inrigorating qi and promoting blood circulation, a promoting the flow of QI in the collateral by warming the meridian ".But above-mentioned two soup sides all lack " the broken knot of removing blood stasis " function, so do not reach desired therapeutic effect clinically; And for example clinical Chinese traditional treatment furuncle, skin ulcer, carbuncle, erysipelas, prescription commonly used adds external application medical ointment, and commonly used decoction is as wuwei xiaodu drink or five refreshing soup or Rhizoma Coptidis toxic materials clearing away decoctions, and external application medical ointment, dash and cream or JINHUANG SAN for the initial stage external application as ill, broken as the affected part, external application five or five pellets or JIUYIDAN.Its pharmacological action: the detoxifcation of relieving inflammation or internal heat, dampness removing, Tuoli detoxifcation, heat-clearing and toxic substances removing.But above-mentioned three flavor decoctions lack general temperatureization, erosion flesh, lead to fixed attention, the eliminating stagnation drug effect.Therefore, the treatment effect that can not realize ideal clinically.
The object of the present invention is to provide a kind of above-mentioned shortcoming that overcomes, and make that its processing technique is simple, a kind of compositions that the active ingredient of taking convenience and medicine can make full use of is primary raw material is controlled the sick medicine of the five poisonous creatures: scorpion, viper, centipede, house lizard, toad (furuncle, skin ulcer, carbuncle, cellulitis, erysipelas) as preparation FUFANG BANMAO JIAONANG with Mylabris etc.
For being achieved in that adjuvant of the present invention, the present invention that achieves the above object mainly contains Radix Trichosanthis, Radix Salviae Miltiorrhizae, Pericarpium Citri Reticulatae, Herba Taraxaci, Herba Hedyotidis Diffusae, Herba Eupatorii, Radix Paeoniae Rubra, Herba Epimedii, the Radix Astragali, Rhizoma Curcumae, PORIA from Yunnan of China, Radix Patriniae heterophyllae is formed, and it is characterized in that: by Mylabris, dry maxima skin, Radix Glycyrrhizae uralensis is that its prescription of FUFANG BANMAO JIAONANG that primary raw material is made is: Mylabris accounts for 0.6-5%, dry maxima skin accounts for 0.6-5%, Radix Trichosanthis accounts for 2-8%, Radix Salviae Miltiorrhizae accounts for 4-15%, Pericarpium Citri Reticulatae accounts for 1-6%, Herba Taraxaci accounts for 4-12%, Herba Hedyotidis Diffusae accounts for 3-12%, Herba Eupatorii accounts for 2-8%, Radix Paeoniae Rubra accounts for 3-10%, Herba Epimedii accounts for 3-10%, the Radix Astragali accounts for 4-15%, Rhizoma Curcumae accounts for 2-8%, PORIA from Yunnan of China accounts for 2-8%, Radix Glycyrrhizae uralensis accounts for 1-6%, Radix Patriniae heterophyllae accounts for 2-8%.
Manufacture method of the present invention, it comprises the clean solarization of choosing cantharides respectively, dry maxima skin, Radix Glycyrrhizae, Radix Trichosanthis, Radix Salviae Miltiorrhizae, Pericarpium Citri Reticulatae, Herba Taraxaci, Herba Hedyotidis Diffusae, Herba Eupatorii, Radix Paeoniae Rubra, Herba Epimedii, the Radix Astragali, Rhizoma Curcumae, PORIA from Yunnan of China, the Radix Patriniae heterophyllae raw material, be characterized in: with the Mylabris foot of decaptitating, dry maxima skin every stir-baking with sand to embrittlement, Radix Glycyrrhizae uralensis is chosen about the downward one-inch of Radix Glycyrrhizae uralensis, be processed into powder more respectively, cross 100 20 mesh, separately contain storage, account for 0.6-5% by Mylabris then, dry maxima skin accounts for 0.6-5%, Radix Trichosanthis accounts for 2-8%, Radix Salviae Miltiorrhizae accounts for 4-15%, Pericarpium Citri Reticulatae accounts for 1-6%, Herba Taraxaci accounts for 4-12%, Herba Hedyotidis Diffusae accounts for 3-12%, Herba Eupatorii accounts for 2-8%, Radix Paeoniae Rubra accounts for 3-10%, Herba Epimedii accounts for 3-10%, the Radix Astragali accounts for 4-15%, Rhizoma Curcumae accounts for 2-8%, PORIA from Yunnan of China accounts for 2-8%, Radix Glycyrrhizae uralensis accounts for 1-6%, Radix Patriniae heterophyllae accounts for the formula proportion of 2-8% and prepares, and then its batching is fully mixed all back after 100 20 mesh; Through allocate into by each capsule after the above-mentioned technological process above-mentioned through combine and after medicated powder 0.15~0.6 gram get final product.
Owing to adopt technique scheme, through clinical verification the five poisonous creatures: scorpion, viper, centipede, house lizard, toad patient that the treatment traditional Chinese medical science is referred to as " furuncle, skin ulcer, carbuncle, cellulitis, erysipelas " there is special effect, and thromboangiitis obliterans, chronic osteomyelitis, acute lymphangitis and other all kinds of inflammation to Western medicine diagnose, evident in efficacy, cure rate is high, and short treating period, expense are low.Technology of the present invention is simple, owing to adopt capsular manufacture method, it is very convenient that it is taken.
Introduce embodiments of the invention below in detail:
Adjuvant of the present invention mainly contains Radix Trichosanthis, Radix Salviae Miltiorrhizae, Pericarpium Citri Reticulatae, Herba Taraxaci, Herba Hedyotidis Diffusae, Herba Eupatorii, Radix Paeoniae Rubra, Herba Epimedii, the Radix Astragali, Rhizoma Curcumae, PORIA from Yunnan of China, Radix Patriniae heterophyllae is formed, by Mylabris, dry maxima skin, Radix Glycyrrhizae uralensis is that its prescription of FUFANG BANMAO JIAONANG that primary raw material is made is: Mylabris accounts for 1%, dry maxima skin accounts for 1%, Radix Trichosanthis accounts for 7%, Radix Salviae Miltiorrhizae accounts for 11%, Pericarpium Citri Reticulatae accounts for 4%, Herba Taraxaci accounts for 10%, Herba Hedyotidis Diffusae accounts for 9%, Herba Eupatorii accounts for 7%, Radix Paeoniae Rubra accounts for 8%, Herba Epimedii accounts for 8%, the Radix Astragali accounts for 11%, Rhizoma Curcumae accounts for 7%, PORIA from Yunnan of China accounts for 5%, Radix Glycyrrhizae uralensis accounts for 4%, Radix Patriniae heterophyllae accounts for 7%.
Manufacture method of the present invention, it comprises the clean solarization of choosing cantharides respectively, dry maxima skin, Radix Glycyrrhizae, Radix Trichosanthis, Radix Salviae Miltiorrhizae, Pericarpium Citri Reticulatae, Herba Taraxaci, Herba Hedyotidis Diffusae, Herba Eupatorii, Radix Paeoniae Rubra, Herba Epimedii, the Radix Astragali, Rhizoma Curcumae, PORIA from Yunnan of China, the Radix Patriniae heterophyllae raw material, with the Mylabris foot of decaptitating, dry maxima skin every stir-baking with sand to embrittlement, Radix Glycyrrhizae uralensis is chosen about the downward one-inch of Radix Glycyrrhizae uralensis, be processed into powder more respectively, cross 100 20 mesh, separately contain storage, account for 1% by Mylabris then, dry maxima skin accounts for 1%, Radix Trichosanthis accounts for 7%, Radix Salviae Miltiorrhizae accounts for 11%, Pericarpium Citri Reticulatae accounts for 4%, Herba Taraxaci accounts for 10%, Herba Hedyotidis Diffusae accounts for 9%, Herba Eupatorii accounts for 7%, Radix Paeoniae Rubra accounts for 8%, Herba Epimedii accounts for 8%, the Radix Astragali accounts for 11%, Rhizoma Curcumae accounts for 7%, PORIA from Yunnan of China accounts for 5%, Radix Glycyrrhizae uralensis accounts for 4%, Radix Patriniae heterophyllae accounts for 7% formula proportion and prepares, and then its batching is fully mixed all the back after 100 20 mesh; Through allocate into by each capsule after the above-mentioned technological process above-mentioned through combine and after medicated powder 0.25 gram get final product.
The present invention also can make the ball shape with the above-mentioned binding agent such as Mel that is equipped with again by formula proportion and the medicated powder after mixed, or directly will take its powder by formula proportion and the medicated powder subpackage after mixing, all within this utility model scope of disclosure.
Mylabris in the present invention's prescription is that " monarch " is promptly main, dry maxima skin, Radix Trichosanthis is that " minister " is promptly auxilliary main, Radix Salviae Miltiorrhizae, the Radix Astragali, Pericarpium Citri Reticulataes etc. are " assistant " medicine, and Radix Glycyrrhizae uralensis is " making " medicine, another principle of prescription, and according to interior warp: " high person presses down it; sinking of QI of ZANG FU-organs should be treated by elevation, subduing excessive pathogen, not enough benefits; using the drugs beneficial to recover the health as an assistant therapy; and suitable with institute, must pacify its host and guest, harmonizing the cool with warmth of the body; patients whose pathogenesis being consistent with symptoms in nature are treated with the routine way; patients whose pathogenesis being not consistent with the symptomes are treated by the reverse way " be through purport, and Mylabris is joined dry maxima skin, can increase removing blood stasis exponentially and break and tie, the counteracting toxic substances detumescence, erosion flesh is treated the effect of tinea, Radix Salviae Miltiorrhizae is joined Herba Taraxaci, Herba Violae forms, promoting blood circulation to remove blood stasis, the heat in purifying the blood, Radix Trichosanthis, Herba Eupatorii, Herba Epimedii, increase body fluid with YIN nourishing, the kidney warming sun and strong waist, the Radix Glycyrrhizae coordinating the actions of various ingredients in a prescription is claimed " paddy is old ", and Radix Glycyrrhizae uralensis is a particular drug in this medicine, be to allocate into according to the purport of interior warp " high person presses down it ", Radix Glycyrrhizae uralensis is joined Mylabris, can suppress the toxic and side effects of Mylabris, increases diuresis, pathogenic factor is discharged from urine, thus the therapeutic efficiency of collaborative Mylabris.
Instructions of taking: at every turn obey 8-12 grain FUFANG BANMAO JIAONANG, sooner or later service once every day, take needs drink boiled water more than 500 milliliters at every turn, chronic as cellulitis, take medicine three courses of treatment, 30 days is a course of treatment, acute as: furuncle, skin ulcer, carbuncle, erysipelas etc. are taken medicine and can be cured about a week.Period in a medicine is avoided the clothes stimulating food, as: cock, Cyprinus carpio, pig head meat, marine products (comprising various seafood).The renal insufficiency person avoids this medicine of clothes.
The clinical trial example:
Medical record 1:
Jiang Hongtao, the man, 50 years old, suffer from the finger furuncle, firmly Sheyang County, Jiangsu Province coupling is ploughed township's coupling and is ploughed three groups in village, go to a doctor on June 5th, 1999, though refer to the routed not gathering in top, swollen all around hard pain, wet fire pents up, and the blood clotting poison stagnates, and the disease gesture is non-light, suddenly suitable removing summer-heat poison holding.Join 100 of FUFANG BANMAO JIAONANG, sooner or later respectively obey 10, external application YUSHIZHI RUANGAO totally twice, taking medicine, it is complete to finish the back.
Case 2:
Zhou Hongyang, the woman, 9 years old, suffer from belly carbuncle, live one group in ring village, eternal lasting township, Sheyang County, Jiangsu Province, go to a doctor on March 12nd, 1999, the belly carbuncle root is big as handleless teacup, the color purple is routed, as hard as flint, pain endlessly, poor appetite, wiry and frequent pulse, red tongue, greasy and thin fur.Join 70 of FUFANG BANMAO JIAONANG, each 5 sooner or later, the external application YUSHIZHI RUANGAO adds the bactrim powder totally 2 times, and is complete after the week.
Case 3:
Jiang Jun, the man, 53 years old, suffer from herpes zoster, plough township's family planning at Sheyang County, Jiangsu Province coupling and do work, go to a doctor on May 5th, 2000, herpes zoster is born between costa sternales, red pimple companion blister, and consecutive becomes rope, and scorching hot twinge is unbearably, so far stringy and tense pulse, red tongue, greasy and thin fur have been suffered from three.Join 200 of FUFANG BANMAO JIAONANG, sooner or later respectively obey 10, be coated with realgar wine day 2 times outward, one week the back complete.
Case 4:
Zhang Yan, the woman, 21 years old, suffer from erysipelas, live seven groups in ring village, eternal lasting township, Sheyang County, Jiangsu Province, go to a doctor on October 19th, 1999, erysipelas is sent out in right lower extremity, and is red and swollen, and color such as pellet are coated with, and causalgia is fidgety, the aversion to cold high fever, diseases caused by exogenous pathogenic factor rheumatism pathogenic heat, inside and outside combined pathogens and cause full and rapid pulse, red tongue, yellow and greasy fur.Join 200 of FUFANG BANMAO JIAONANG, each 10 sooner or later, head examines the back rehabilitation.
Case 5:
Li Fugao, the man, 53 years old, suffer from two limb thromboangiitis obliterans, belong to traditional Chinese medical science necrosis model and raise, live four groups in eternal lasting angle of rest (repose) village, Sheyang County, Jiangsu Province.
Head was examined on February 18th, 2000, the patient is between in December, 1999, two lower limb of special sense such as chicken peck sample pain, blue, gradually black, the swelling of commentaries on classics that skin is seen, symptom is on the rise, and once village, township's secondary commune hospital check treatment two wheat harvesting periods, obey Chinese medicine, used Drug therapys such as penicillin not imitate, the state of an illness progressively worsens, and can not walk, escorts diagnosis and treatment by tractor and four men.At that time ten toe ulcerations February surplus, be necrosis serious symptom also.Primary disease has taked to join 480 of FUFANG BANMAO JIAONANG, and earlier clothes are 30 days, and each 8 sooner or later of every days, and join five doses of SIMIAOYONGAN TANG, five days dosage is taken with FUFANG BANMAO JIAONANG, simultaneously, joins Western medicine penicillin 8,000,000 units, once-a-day, and quiet totally five staggering amounts;
Two were examined on March 21st, 2000, the disease commentaries on classics of getting better, and two lower limb pains alleviate, and local swelling fades, pus reduces, skin is purple black in changeing light, progressively takes a turn for the better.Two examine and have taked to join 600 of FUFANG BANMAO JIAONANG, obey 30 staggering amounts, each 10 sooner or later of every days;
Three were examined on April 22nd, 2000, the gesture of existing rehabilitation, and two limb pain are lost to the greatest extent, and local swelling is disappeared fully, and pus removes to the greatest extent, skin exfoliation one deck, atropurpureus is moved back to the greatest extent, and ten toes are sound, can carry out walking and walk, and complexion has China, weight increase, arteries and veins is visited strong, and healing is expected to.Continue with 660 of FUFANG BANMAO JIAONANG, every day, each once each 11, was consolidated all around and rehabilitation sooner or later.

Claims (2)

1, a kind of FUFANG BANMAO JIAONANG, adjuvant mainly contains Radix Trichosanthis, Radix Salviae Miltiorrhizae, Pericarpium Citri Reticulatae, Herba Taraxaci, Herba Hedyotidis Diffusae, Herba Eupatorii, Radix Paeoniae Rubra, Herba Epimedii, the Radix Astragali, Rhizoma Curcumae, PORIA from Yunnan of China, Radix Patriniae heterophyllae is formed, it is characterized in that: by Mylabris, dry maxima skin, Radix Glycyrrhizae uralensis is the FUFANG BANMAO JIAONANG that primary raw material is made, and its prescription is: Mylabris accounts for 0.6-5%, dry maxima skin accounts for 0.6-5%, Radix Trichosanthis accounts for 2-8%, Radix Salviae Miltiorrhizae accounts for 4-15%, Pericarpium Citri Reticulatae accounts for 1-6%, Herba Taraxaci accounts for 4-12%, Herba Hedyotidis Diffusae accounts for 3-12%, Herba Eupatorii accounts for 2-8%, Radix Paeoniae Rubra accounts for 3-10%, Herba Epimedii accounts for 3-10%, the Radix Astragali accounts for 4-15%, Rhizoma Curcumae accounts for 2-8%, PORIA from Yunnan of China accounts for 2-8%, Radix Glycyrrhizae uralensis accounts for 1-6%, Radix Patriniae heterophyllae accounts for 2-8%.
2, the manufacture method of a kind of FUFANG BANMAO JIAONANG according to claim 1, it comprises the clean solarization of choosing cantharides respectively, dry maxima skin, Radix Glycyrrhizae, Radix Trichosanthis, Radix Salviae Miltiorrhizae, Pericarpium Citri Reticulatae, Herba Taraxaci, Herba Hedyotidis Diffusae, Herba Eupatorii, Radix Paeoniae Rubra, Herba Epimedii, the Radix Astragali, Rhizoma Curcumae, PORIA from Yunnan of China, the Radix Patriniae heterophyllae raw material, it is characterized in that: with the Mylabris foot of decaptitating, dry maxima skin every stir-baking with sand to embrittlement, Radix Glycyrrhizae uralensis is chosen about the downward one-inch of Radix Glycyrrhizae uralensis, be processed into powder more respectively, cross 100 20 mesh, separately contain storage, account for 0.6-5% by Mylabris then, dry maxima skin accounts for 0.6-5%, Radix Trichosanthis accounts for 2-8%, Radix Salviae Miltiorrhizae accounts for 4-15%, Pericarpium Citri Reticulatae accounts for 1-6%, Herba Taraxaci accounts for 4-12%, Herba Hedyotidis Diffusae accounts for 3-12%, Herba Eupatorii accounts for 2-8%, Radix Paeoniae Rubra accounts for 3-10%, Herba Epimedii accounts for 3-10%, the Radix Astragali accounts for 4-15%, Rhizoma Curcumae accounts for 2-8%, PORIA from Yunnan of China accounts for 2-8%, Radix Glycyrrhizae uralensis accounts for 1-6%, Radix Patriniae heterophyllae accounts for the formula proportion of 2-8% and prepares, and then its batching is fully mixed all back after 100 20 mesh; Allocating above-mentioned medicated powder 0.15~0.6 gram into by each capsule after above-mentioned technological process gets final product.
CN00122180A 2000-08-03 2000-08-03 Compound Wuduqing capsule of blister beetle Expired - Fee Related CN1132603C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN00122180A CN1132603C (en) 2000-08-03 2000-08-03 Compound Wuduqing capsule of blister beetle

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN00122180A CN1132603C (en) 2000-08-03 2000-08-03 Compound Wuduqing capsule of blister beetle

Publications (2)

Publication Number Publication Date
CN1337250A CN1337250A (en) 2002-02-27
CN1132603C true CN1132603C (en) 2003-12-31

Family

ID=4589145

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00122180A Expired - Fee Related CN1132603C (en) 2000-08-03 2000-08-03 Compound Wuduqing capsule of blister beetle

Country Status (1)

Country Link
CN (1) CN1132603C (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100478019C (en) * 2006-04-29 2009-04-15 上海交通大学医学院附属第九人民医院 Medicinal pill, watered pill, honeyed pill for treating liver cancer and method for preparing same
CN100478018C (en) * 2006-04-29 2009-04-15 上海交通大学医学院附属第九人民医院 A medicine for treating liver cancer and method for preparing same
CN107261061B (en) * 2017-06-23 2018-06-19 邓圣平 A kind of Chinese medicine composition for treating malignant tumour, preparation method and its preparation

Also Published As

Publication number Publication date
CN1337250A (en) 2002-02-27

Similar Documents

Publication Publication Date Title
CN102319350B (en) External scald oil medicinal composition for treating burns and scalds
CN100388932C (en) Method for preparing externally applied medicine for feet tinea
CN103463528A (en) Traditional Chinese medicine composition for treating chronic eczema
CN106620370A (en) Traditional Chinese medicine for treating beriberi
CN1240416C (en) Medicine for curing hypertension and its preparation method
CN101919944B (en) Traditional Chinese medicine compound, preparation method and application thereof
CN103055222A (en) Medicine for treating tinea manus and pedis
CN102462827A (en) Traditional Chinese medicinal powder formulation for treating postpartum mastitis of Boer goat
CN102631538B (en) Traditional Chinese medicine for treating heart disease
CN1132603C (en) Compound Wuduqing capsule of blister beetle
CN111298053A (en) Bezoar dragon bone ointment for treating hemorrhoid
CN102895610A (en) Medicine for treating edema
CN104873911B (en) A kind of pyemic traditional Chinese medicine for oral administration of auxiliary treatment
CN102327524A (en) Traditional Chinese medicine composition for curing erysipelas
CN102727694B (en) Compound propolis composition used for treating broiler ascites syndrome, and preparation method thereof
CN105561272A (en) Traditional Chinese medicine preparation for relieving Reynolds disease and preparation method thereof
CN100423767C (en) Medicine for curing burn and scald wound and its preparation method
CN1245197C (en) Chinese medicine preparation for treating coronary heart disease and viral myocarditis
CN110496199B (en) Medicine for treating psoriasis and preparation method thereof
CN103007170B (en) Chinese medicinal composition for treating recurrent oral ulcer
CN101983712A (en) Novel medicament for treating coronary heart disease
CN106620203A (en) Traditional Chinese medicine composition for treating laminitis of cows
CN106620140A (en) Traditional Chinese medicine composition for treating foot rot of buffaloes
CN1927349A (en) Traditional Chinese medicine for treating rheumatism and its preparing process
CN104887825A (en) Traditional Chinese medicine prescription for curing eczema and preparation method thereof

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee